Potential jurors don't hold back in the Martin Shkreli trial

1:51 PM ET Tue, 27 June 2017

Jury selection in the securities fraud trial of Martin Shkreli got off to a slow start Monday as multiple potential jurors expressed disdain for the notorious "pharma bro," who gained infamy in 2015 by raising a drug price by more than 5,000 percent.